Emergent Biosolutions Canada Inc.
Winnipeg, MB
- UEI
- XM23STFMVML6
- CAGE
- L0EM2
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- Cangene Corporation 155 Innovation Drive, 155 Innovation Dr, Winnipeg, MB R3T 5Y3, Canada
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| 8509633281 ! Reactive skin decon | Medical Supply Chain | $108,377 | |
| 8508283491 ! Training aid,reacti | Medical Supply Chain | $4,285 | |
| 8508231182 ! Reactive skin decon | Medical Supply Chain | $123,191 | |
| "covid-19" development of human immune globulin (covid-HIG) manufactured from human plasma with antibodies to sars-COV-2… | ACC Aberdeen Proving Ground | $34,568,578 | |
| 8506882819 ! Reactive skin decon | Medical Supply Chain | $95,220 |
About Emergent Biosolutions Canada Inc.
Emergent Biosolutions Canada Inc. is a for-profit organization that provides medical countermeasures to the U.S. government, including therapeutics and vaccines against chemical, biological, radiological and nuclear threats. Through federal contracts, the company supplies skin decontamination lotion, botulism antitoxin, and immune globulin to prevent and treat diseases.
Emergent has received over $770 million in federal contracts from agencies like the Defense Logistics Agency and the Department of Health and Human Services. As a prime contractor, it has provided skin decontamination lotion to the Defense Logistics Agency under purchase orders without set aside designations. It also holds multi-year definitive contracts valued at $133 million and $600 million with the HHS Office of the Assistant Secretary for Preparedness and Response to supply botulism antitoxin and vaccinia immune globulin. Additionally, Emergent received a $34 million Other Transaction Agreement from the Department of the Army to develop a COVID-19 therapy. As a subcontractor, Emergent has worked with the Canadian Commercial Corporation to manufacture reactive skin decontamination lotion.
Quick answers
What is Emergent Biosolutions Canada Inc.'s UEI?
Emergent Biosolutions Canada Inc.'s Unique Entity ID (UEI) in SAM.gov is XM23STFMVML6.
What is Emergent Biosolutions Canada Inc.'s CAGE code?
Emergent Biosolutions Canada Inc.'s CAGE code is L0EM2.
What is Emergent Biosolutions Canada Inc.'s primary NAICS code?
Emergent Biosolutions Canada Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Emergent Biosolutions Canada Inc. located?
Emergent Biosolutions Canada Inc.'s physical address in SAM.gov is Cangene Corporation 155 Innovation Drive, 155 Innovation Dr, Winnipeg, MB R3T 5Y3, Canada.
Is Emergent Biosolutions Canada Inc. registered in SAM.gov?
Yes. Emergent Biosolutions Canada Inc.'s SAM.gov registration is active through September 24, 2027.
What is Emergent Biosolutions Canada Inc.'s most recent federal award?
Emergent Biosolutions Canada Inc.'s most recent federal contract award is 8509633281 ! Reactive skin decon (SPE2DP23P0208), from Medical Supply Chain, on January 11, 2023.
On GovTribe
See Emergent Biosolutions Canada Inc.'s full federal record
- Federal contract awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors